South African pharmaceutical company Aspen Pharmacare announced on Monday, December 29th, the sale of its main Asia-Pacific operations (excluding China) to Australian private equity fund BGH Capital for 2.37 billion Australian dollars, approximately 1.59 billion US dollars. This transaction, which includes markets in Australia, New Zealand, Hong Kong, Taiwan, Malaysia, and the Philippines, is part...
Trending
- AFIS 2026: BRVM advocates for increased integration of African capital markets
- InsurTech in Africa: Over $300 million invested in five years
- Senegal, banks: APBEF-SN adopts a new visual identity
- Allegria Ntumba Luaba appointed Director of Business Development at AfCRA
- Luanda Biennial: Félix Tshisekedi defends DRC’s sovereignty over its water resources
- Daily news from African financial markets
- AFINHAB: 100 billion FCFA of Social Bonds to expand household access to mortgage credit
- Cameroon: GECAM President Involved in Land Dispute That Undermines Private Investment
South African Aspen Pharmacare sells key Asia-Pacific operations for $1.6 billion
By Félix NZALÉ
Félix NZALÉ
Félix Nzalé is a Senegalese journalist with a deep passion for cultural issues. He led the "CULTURE" section of SUD QUOTIDIEN (SUD Communication Group) for 10 years. Holder of dual Master’s degrees in Sociology and Philosophy, he also holds a management diploma from the Institut Supérieur de Management (ISM) in Dakar. He has contributed to the development of editorial concepts for several newspapers in Dakar.
Add A Comment
About us
Headed by Adama Wade and his team of 20 journalists, Kapital Afrik offers strategic and financial information to executives and managers. The aim of Kapital Afrik is to provide financial and political news, give priority to human entrepreneurial experiences, lend life to economic policies, give meaning to statistics….
Contact us: redaction@financialafrik.com